End Stage Renal Disease Clinical Trials in New York, New York
3 recruitingNew York, New York
Showing 1–3 of 3 trials
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420
Recruiting
Not Applicable
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
HemodialysisEnd Stage Renal Disease (ESRD)Kidney Failure+1 more
W.L.Gore & Associates133 enrolled21 locationsNCT04671771
Recruiting
Phase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
NYU Langone Health60 enrolled2 locationsNCT05786443